PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $311,667 | +73.2% | 30,171 | +119.8% | 0.00% | – |
| Q2 2023 | $179,947 | -90.8% | 13,726 | -92.1% | 0.00% | -100.0% |
| Q1 2023 | $1,954,476 | +1774.4% | 174,819 | +1313.4% | 0.00% | – |
| Q4 2022 | $104,271 | -54.7% | 12,369 | -10.5% | 0.00% | – |
| Q3 2022 | $230,000 | +29.2% | 13,824 | +14.8% | 0.00% | – |
| Q2 2022 | $178,000 | -32.1% | 12,039 | +13.7% | 0.00% | – |
| Q1 2022 | $262,000 | -24.3% | 10,592 | -1.9% | 0.00% | – |
| Q4 2021 | $346,000 | -18.8% | 10,793 | -8.7% | 0.00% | – |
| Q3 2021 | $426,000 | -94.4% | 11,815 | -93.2% | 0.00% | -100.0% |
| Q2 2021 | $7,612,000 | -11.2% | 172,524 | -7.9% | 0.00% | 0.0% |
| Q1 2021 | $8,571,000 | -50.5% | 187,395 | -25.3% | 0.00% | -60.0% |
| Q4 2020 | $17,309,000 | – | 250,773 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $1,494,000 | 12.13% |
| Miura Global Management | 595,000 | $14,762,000 | 4.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,695,341 | $91,681,000 | 2.05% |
| Millrace Asset Group, Inc. | 78,859 | $1,956,000 | 1.42% |
| NEXT CENTURY GROWTH INVESTORS LLC | 436,034 | $10,818,000 | 1.08% |
| Novo Holdings A/S | 410,155 | $10,176,000 | 0.54% |
| PURA VIDA INVESTMENTS, LLC | 589,722 | $14,631,000 | 0.47% |
| Rock Springs Capital Management LP | 702,400 | $17,427,000 | 0.44% |
| RTW INVESTMENTS, LP | 798,255 | $19,805,000 | 0.41% |
| Regis Management CO LLC | 82,070 | $2,036,000 | 0.36% |